JIC
LMAT icon

Johnson Investment Counsel’s LeMaitre Vascular LMAT Stock Holding History

Johnson Investment Counsel’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Buy
24,329
+230
+1% +$23.6K 0.02% 309
2026
Q1 		$2.63M Sell
24,099
-5,618
-19% -$535K 0.02% 278
2025
Q4 		$2.41M Sell
29,717
-75
-0.3% -$6.46K 0.02% 280
2025
Q3 		$2.61M Buy
29,792
+153
+0.5% +$13.7K 0.02% 266
2025
Q2 		$2.46M Buy
29,639
+211
+0.7% +$17.6K 0.02% 263
2025
Q1 		$2.47M Buy
29,428
+7,603
+35% +$707K 0.02% 248
2024
Q4 		$2.01M Hold
21,825
– – 0.02% 286
2024
Q3 		$2.03M Sell
21,825
-8,800
-29% -$762K 0.02% 286
2024
Q2 		$2.52M Sell
30,625
-10,990
-26% -$807K 0.03% 232
2024
Q1 		$2.76M Buy
41,615
+300
+0.7% +$18.5K 0.03% 219
2023
Q4 		$2.35M Buy
41,315
+8,570
+26% +$449K 0.03% 230
2023
Q3 		$1.78M Buy
32,745
+11,280
+53% +$668K 0.02% 261
2023
Q2 		$1.44M Sell
21,465
-11,580
-35% -$706K 0.02% 307
2023
Q1 		$1.7M Hold
33,045
– – 0.02% 268
2022
Q4 		$1.52M Sell
33,045
-120
-0.4% -$5.62K 0.02% 283
2022
Q3 		$1.68M Hold
33,165
– – 0.02% 246
2022
Q2 		$1.51M Hold
33,165
– – 0.02% 269
2022
Q1 		$1.54M Hold
33,165
– – 0.02% 278
2021
Q4 		$1.67M Buy
+33,165
New +$1.71M 0.02% 268
2018
Q4 		– Sell
-62,903
Closed -$2.44M – 626
2018
Q3 		$2.44M Buy
62,903
+5,635
+10% +$203K 0.05% 186
2018
Q2 		$1.92M Buy
57,268
+20,375
+55% +$725K 0.05% 199
2018
Q1 		$1.34M Buy
+36,893
New +$1.28M 0.03% 223

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Johnson Investment Counsel's LMAT Position: Q2 2026 in Review

Johnson Investment Counsel increased its LeMaitre Vascular (LMAT) stake by 0.95% in Q2 2026, buying an estimated $23.6K and bringing the position to 24,329 shares worth $2.33M. The position accounts for 0.02% of the portfolio, ranked #309.

Johnson Investment Counsel first reported a position in LMAT in Q1 2018 and has held it in 22 quarters since. The position peaked at $2.76M in Q1 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Johnson Investment Counsel held 24,329 shares of LeMaitre Vascular worth $2.33M as of Q2 2026.
  • Johnson Investment Counsel bought 230 LeMaitre Vascular shares in Q2 2026, an estimated $23.6K.
  • LeMaitre Vascular made up 0.02% of Johnson Investment Counsel's portfolio in Q2 2026, its #309 holding.
  • Johnson Investment Counsel first reported a position in LeMaitre Vascular in Q1 2018 and has held it in 22 quarters since.
  • Johnson Investment Counsel's LeMaitre Vascular position peaked at $2.76M in Q1 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.